Abstract: Soft robotics is growing as a leading approach to the development of soft bionic limbs. This paper proposes a solution to the problems caused by the complex structure, limited flexibility, ...
It’s no secret that hormone replacement therapy is making a comeback. This treatment for symptoms of menopause fell out of favor in the early 2000s after a study suggested it could do more harm than ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Been targeted by a scam? Get free assistance from the AARP Fraud ...
For years, hormone therapy (HT) had earned a bad rep it just couldn’t shake. Many women who might have benefited never even considered the treatment, thrown off by the Food & Drug Administration's ...
Women experiencing menopause have long weathered uncomfortable symptoms in silence. Advancements in menopause care include personalized hormone therapy, telehealth support, and non-hormonal therapies.
On November 26, 2025, the U.S. Patent and Trademark Office issued new inventorship guidance (formally published on November 28) clarifying how inventorship should be ...
The global Cream of Tartar Market is estimated to be valued at USD 274.2 million in 2025 and is projected to reach USD 491.0 million by 2035, registering a compound annual growth rate (CAGR) of 6.0% ...
Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026 If approved, ZORYVE cream 0.3% would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in ...
(CNN) — On Monday, US Health and Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Dr. Marty Makary announced that after 20 years, they were righting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback